Wang Fangce, Li Zheng, Wang Guangming, Tian Xiaoxue, Zhou Jie, Yu Wenlei, Fan Zhuoyi, Dong Lin, Lu Jinyuan, Xu Jun, Zhang Wenjun, Liang Aibin
Department of Hematology, Tongji Hospital, Tongji University School of Medicine, Shanghai 200092, P.R. China.
Medical Center for Stem Cell Engineering and Transformation, East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China.
Mol Med Rep. 2021 Sep;24(3). doi: 10.3892/mmr.2021.12295. Epub 2021 Jul 19.
Following the publication of this paper, the authors have realized that the final article did not indicate in the Authors' Contribution section that Fangce Wang and Zheng Li made equal contributions to this work (FW and ZL performed most of the statistical analyses and drafted the initial version of the manuscript). Therefore, the affiliations for this paper should have been written as follows (changes are highlighted in bold): FANGCE WANG, ZHENG LI, GUANGMING WANG, XIAOXUE TIAN, JIE ZHOU, WENLEI YU, ZHUOYI FAN, LIN DONG, JINYUAN LU, JUN XU, WENJUN ZHANG and AIBIN LIANG Department of Hematology, Tongji Hospital, Tongji University School of Medicine, Shanghai 200092; Medical Center for Stem Cell Engineering and Transformation, East Hospital, Tongji University School of Medicine, Shanghai 200120, P.R. China. Contributed equally. The authors confirm that there are no further errors in the paper, and all the authors agree to this correction. The authors and the Editor apologize for any inconvenience caused. [the original article was published in 21: 883‑893, 2020, DOI: 10.3892/mmr.2019.10849].
在本文发表之后，作者们意识到最终发表的文章在“作者贡献”部分未表明王方策和李政对本工作做出了同等贡献（王方策和李政进行了大部分统计分析并起草了稿件的初稿）。因此，本文的作者单位应如下书写（更改部分用粗体突出显示）：王方策、李政、王光明、田小雪、周杰、于文磊、范卓一、董琳、卢金元、徐军、张文军、梁爱斌 同济大学医学院附属同济医院血液科，上海 200092；同济大学医学院附属东方医院干细胞工程与转化医学中心，上海 200120，中国。同等贡献。作者确认本文不存在进一步错误，所有作者均同意此更正。作者和编辑就由此造成的任何不便表示歉意。[原文发表于《分子医学报告》21: 883 - 893, 2020, DOI: 10.3892/mmr.2019.10849]
